The Section of Pulmonary, Critical Care, and Sleep Medicine at Baylor College of Medicine is nationally recognized for its excellence in healthcare, research and education.
The section has total research support of $4.8 million from federal and private research grants including lung cancer, asthma, COPD, pulmonary hypertension, pulmonary fibrosis, transitional medicine, lung transplant, and cystic fibrosis.
Many physicians from the section are national and international experts. Together, they offer an incredibly large array of services, from general pulmonary and sleep medicine to highly specialized advanced lung diseases, such as including pulmonary hypertension, pulmonary fibrosis, adult cystic fibrosis, COPD/asthma, interstitial lung disease, lung and heart-lung transplantation, critical care, and interventional pulmonology.
The section offers four fellowship programs, including Pulmonary & Critical Care, Critical Care Medicine, Lung Transplantation, and Sleep Medicine. Many alumni and former fellows can be found in academic, research and healthcare leadership roles.
- Goodman named chair of psychiatry and behavioral sciences at Baylor College of MedicineYesterday
- Dr. Wayne Goodman has been named to lead the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine.
- Baylor College of Medicine Announces 13th Annual Michael E. DeBakey Medical Student Poetry AwardsJul 27, 2016
- The winners of the 13th Annual Michael E. DeBakey Medical Student Poetry Award were chosen from original poems submitted by undergraduates currently enrolled in accredited United States medical schools.
- Expert says sleep is essential on road trips Jul 27, 2016
- Dr. Philip Alapat explains the importance of getting enough sleep to ensure safe and fun road trips.
- Indoor allergies can flare during dog days of summerJul 26, 2016
- A Baylor allergy expert offers tips for reducing indoor allergens and some treatment options.
- Visual pigment rhodopsin forms two-molecule complexes in vivoJul 25, 2016
- Researchers have determined the most likely configuration of rhodopsin in a living organism, a discovery which may help develop future therapies a degenerative eye disease.